The University of Arizona is terminating its Writing Skills Improvement Program, a move that closes the door for students to receive instruction from specialists with professional degrees in writing, ...

The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. There's definitely ...